Expert commentary on the use of GLP-1 receptor agonists in the management of patients with type 2 diabetes
CCO slides: patient-specific guidance on T2D treatment options and insights on managing CVD and CKD risk.
Get patient-specific guidance on T2D treatment options and insights on managing CVD and CKD risk, from Clinical Care Options (CCO)
Enter type 2 diabetes patient characteristics in this online CCO tool and compare your treatment plan with those of 5 experts
Southern Medical Association, CME Division
3500 Blue Lake Drive, Suite 360
Birmingham, AL 35243
Tel: 800.423.4992, ext. 620
Email: Education@sma.org
Website: http://sma.org
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.